Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Ceftolozane Sulfate

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Long-Term Drug Shortage – Zerbaxa® (ceftolozane/tazobactam)
    Long-Term Drug Shortage – Zerbaxa® (ceftolozane/tazobactam)

    12 Oct 2021

    // PROFESSIONALS

    https://professionals.optumrx.com/content/dam/optum3/professional-optumrx/news/rxnews/drug-recalls-shortages/drugshortage_zerbaxa_2021-0423.pdf

    PROFESSIONALS
    12 Oct 2021
    Share Share
    Enforcement Report - Week of January 13, 2021
    Enforcement Report - Week of January 13, 2021

    13 Jan 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-13-2021-1610520934.pdf

    FDA
    13 Jan 2021
    Share Share
    Enforcement Report - Week of January 6, 2021
    Enforcement Report - Week of January 6, 2021

    06 Jan 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-6-2021-1609918562.pdf

    FDA
    06 Jan 2021
    Share Share
    Health Canada Issues Recall Merck Canada Inc's Zerbaxa
    Health Canada Issues Recall Merck Canada Inc's Zerbaxa

    18 Dec 2020

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-merck-canada-incs-zerbaxa-1608715038.pdf

    HEALTH CANADA
    18 Dec 2020
    Share Share
    Ceftolozane/tazobactam: New treatment option for severe infections
    Ceftolozane/tazobactam: New treatment option for severe infections

    02 Jul 2020

    // MEDICALXPRESS

    https://medicalxpress.com/news/2020-07-ceftolozanetazobactam-treatment-option-severe-infections.html

    MEDICALXPRESS
    02 Jul 2020
    Share Share
    EMA committee recommends approval of Merck's Zerbaxa 3g dose
    EMA committee recommends approval of Merck's Zerbaxa 3g dose

    31 Jul 2019

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=117266&sid=2

    PHARMABIZ
    31 Jul 2019
    Share Share